| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.1998.TB09730.X |
| P698 | PubMed publication ID | 9668401 |
| P2093 | author name string | Chiriboga CA | |
| P2860 | cites work | Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants | Q24563036 |
| Prenatal cocaine exposure: effects on the development of school-age children | Q28298730 | ||
| Abnormalities of the visual system in infants exposed to cocaine | Q28319520 | ||
| Seizures induced by the cocaine metabolite benzoylecgonine in rats | Q28319951 | ||
| Neonatal cocaine-related seizures | Q28333027 | ||
| Fetal coronary thrombosis as a cause of single ventricular heart | Q28335334 | ||
| Effects of maternal marijuana and cocaine use on fetal growth | Q34679737 | ||
| Neurobiology of cocaine abuse | Q36208834 | ||
| The biologic and social consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross-sectional study | Q39253689 | ||
| Association between prenatal cocaine exposure and sudden infant death syndrome | Q39263402 | ||
| Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring | Q39407335 | ||
| New concepts in cocaine addiction: the dopamine depletion hypothesis | Q39497896 | ||
| Cocaine metabolites in the neonate: potential for toxicity | Q40634917 | ||
| Effect of prenatal cocaine on respiration, heart rate, and sudden infant death syndrome | Q41145284 | ||
| Maternal cocaine addiction. II: An animal model for the study of brainstem mechanisms operative in sudden infant death syndrome | Q41176268 | ||
| Cocaine effects on the developing central nervous system: behavioral, psychopharmacological, and neurochemical studies | Q41249525 | ||
| Effects of maternal cocaine abuse on the neonatal auditory system | Q42210495 | ||
| Perinatal cerebral infarction and maternal cocaine use. | Q42226745 | ||
| Neurologic findings in neonates with intrauterine cocaine exposure | Q42558298 | ||
| Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates | Q43537952 | ||
| Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates | Q44370749 | ||
| Trends in reporting of maternal drug abuse and infant mortality among drug-exposed infants in New York City | Q44784693 | ||
| Sudden infant death syndrome in infants of substance-abusing mothers | Q46132038 | ||
| Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants | Q47397436 | ||
| Teratogenicity of cocaine in humans | Q47877811 | ||
| Reinforcing properties of cocaine in the medical prefrontal cortex: primary action on presynaptic dopaminergic terminals | Q48329336 | ||
| Brain-stem transmission time in infants exposed to cocaine in utero | Q48889818 | ||
| Prenatal cocaine exposure effects on arousal-modulated attention during the neonatal period. | Q51009511 | ||
| Modification of acoustic startle reactivity by cocaine administration during the postnatal period: comparison with a specific serotonin reuptake inhibitor. | Q51020687 | ||
| Cocaine-abusing parturients undergoing cesarean section. A cohort study. | Q51559099 | ||
| New evidence for neurobehavioral effects of in utero cocaine exposure. | Q51561669 | ||
| Determination of cocaine usage in pregnant women by a urinary EMIT drug screen and GC-MS analyses. | Q51625698 | ||
| The transfer of cocaine and its metabolites across the term human placenta. | Q51670689 | ||
| Motor assessment of cocaine/polydrug exposed infants at age 4 months | Q51694765 | ||
| Maternal cocaine use and infant behavior. | Q51715078 | ||
| Determination of gestational cocaine exposure by hair analysis. | Q51744694 | ||
| Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. | Q51749582 | ||
| Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. | Q51750214 | ||
| Depressive symptoms during pregnancy: relationship to poor health behaviors. | Q51753622 | ||
| Temporal patterns of cocaine use in pregnancy. Perinatal outcome. | Q51755565 | ||
| Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. | Q51759217 | ||
| Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers. | Q51763924 | ||
| Risk of sudden infant death syndrome among infants with in utero exposure to cocaine. | Q51765424 | ||
| Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. | Q51769160 | ||
| Effect of cocaine on uterine blood flow and fetal oxygenation. | Q51794542 | ||
| Teratogenic potential of cocaine hydrochloride in CF-1 mice. | Q51876143 | ||
| Three-year course of behavioral/emotional problems in a national sample of 4- to 16-year-olds: II. Predictors of syndromes | Q52041858 | ||
| Toward a clearer definition of confounding. | Q52404410 | ||
| Cocaine-exposed Children | Q56637145 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 109-125 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Neurological correlates of fetal cocaine exposure | |
| P478 | volume | 846 |
| Q33832749 | Clinical teratology: identifying teratogenic risks in humans |
| Q26996467 | Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions |
| Q30660506 | Neurological and developmental effects of HIV and AIDS in children and adolescents |
| Q51975916 | Visuospatial working memory in school-aged children exposed in utero to cocaine. |
Search more.